Generally, chemotherapy-induced ovarian failure (CIOF) was defined as the presence of either amenorrhea for 12 months, or follicle stimulating hormone (FSH) levels in the post-menopausal range, often at 6 months to 2 years after chemotherapy, or a combination of these [9]. Here, BRD2 is linked to ovarian dysfunction.